Published Aug 02, 2023 07:13AM ET
HUM +0.28% Add to/Remove from Watchlist UNH -0.32% Add to/Remove from Watchlist
Investing.com — Health insurance group Humana (NYSE: ) reported a bump in second-quarter medical costs that was lower than anticipated despite strong demand for surgeries following the COVID-19 pandemic, boosting profit above estimates.
Humana, along with peer UnitedHealth (NYSE: ), warned in June that medical expenses would jump in 2023 as more patients go ahead with elective procedures that had been delayed by the pandemic. Staffing shortages and health restrictions meant that many surgeries, particularly those on older adults at greater risk of contracting severe COVID-19, were previously put on hold.
Analysts have also noted that aging in the so-called
Humana earnings beat estimates as medical costs jump by less-than-expected
